Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial

Should Erlotinib Be Coadministered With Whole-Brain Radiotherapy in Patients With Brain Metastases and Non–Small-Cell Lung Cancer?

(2013) Marc C. Chamberlain   JOURNAL OF CLINICAL ONCOLOGY

Does Quality of Life Supplant Survival in Patients With Brain Metastasis?

(2013) Marc C. Chamberlain   JOURNAL OF CLINICAL ONCOLOGY

Reply to D.C. Currow et al

(2013) Neha Jeurkar et al.   JOURNAL OF CLINICAL ONCOLOGY

Is There a Role for Bevacizumab in the Treatment of Glioblastoma?

(2013) A. S. Chi et al.   ONCOLOGIST

Is Graded Prognostic Assessment an Improvement Compared With Radiation Therapy Oncology Group's Recursive Partitioning Analysis Classification for Brain Metastases?

(2012) Marc C. Chamberlain et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of extent of resection for recurrent glioblastoma on overall survival

(2012) Orin Bloch et al.   JOURNAL OF NEUROSURGERY

Surgery, a prognostic marker for progression-free survival?

(2012) M. C. Chamberlain et al.   NEURO-ONCOLOGY

Convection-enhanced delivery of a transforming growth factor- 2 inhibitor trabedersen for recurrent high-grade gliomas: efficacy real or imagined?, in reference to Bogdahn et al. (Neuro-Oncology 2011;13:132-142)

(2011) M. C. Chamberlain   NEURO-ONCOLOGY

Independent association of extent of resection with survival in patients with malignant brain astrocytoma

(2008) Matthew J. McGirt et al.   JOURNAL OF NEUROSURGERY